Truist Financial Corp Sells 1,002 Shares of Avantor, Inc. (NYSE:AVTR)

Truist Financial Corp lessened its stake in Avantor, Inc. (NYSE:AVTR) by 1.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 89,382 shares of the company’s stock after selling 1,002 shares during the period. Truist Financial Corp’s holdings in Avantor were worth $2,041,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of AVTR. Fifth Third Bancorp raised its stake in shares of Avantor by 125.3% during the fourth quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock valued at $28,000 after acquiring an additional 694 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt increased its holdings in Avantor by 565.5% during the 4th quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,331 shares of the company’s stock valued at $30,000 after purchasing an additional 1,131 shares during the period. GAMMA Investing LLC bought a new position in Avantor during the 4th quarter valued at approximately $47,000. CKW Financial Group purchased a new stake in Avantor in the 4th quarter worth approximately $55,000. Finally, ORG Partners LLC purchased a new stake in Avantor in the 4th quarter worth approximately $89,000. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

AVTR has been the subject of a number of recent analyst reports. Citigroup upped their target price on Avantor from $24.00 to $30.00 and gave the company a “buy” rating in a report on Thursday, February 15th. Barclays upped their price target on Avantor from $27.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 10th. UBS Group raised their target price on shares of Avantor from $25.00 to $29.00 and gave the company a “buy” rating in a research note on Thursday, February 15th. JPMorgan Chase & Co. boosted their price target on Avantor from $26.00 to $29.00 and gave the stock an “overweight” rating in a research report on Thursday, February 15th. Finally, Robert W. Baird reduced their price objective on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research report on Monday, April 29th. Four analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $26.71.

Avantor Price Performance

NYSE AVTR opened at $24.78 on Friday. Avantor, Inc. has a one year low of $16.63 and a one year high of $26.16. The stock has a 50-day moving average of $25.10 and a 200 day moving average of $22.81. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.05 and a current ratio of 1.61. The company has a market capitalization of $16.83 billion, a price-to-earnings ratio of 63.54, a PEG ratio of 1.50 and a beta of 1.36.

Avantor (NYSE:AVTR) last announced its quarterly earnings results on Friday, April 26th. The company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $0.02. The firm had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.68 billion. Avantor had a net margin of 3.79% and a return on equity of 13.01%. The business’s revenue for the quarter was down 5.6% on a year-over-year basis. During the same period in the previous year, the business posted $0.29 earnings per share. On average, sell-side analysts forecast that Avantor, Inc. will post 1.01 EPS for the current year.

Insider Buying and Selling at Avantor

In other news, EVP James Bramwell sold 6,203 shares of the firm’s stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total value of $151,911.47. Following the transaction, the executive vice president now directly owns 101,143 shares in the company, valued at approximately $2,476,992.07. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 1.50% of the company’s stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.